In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Near-Infrared Fluorescence-Guided Stereotactic Biopsy of High Grade Glioma

    Final Number:
    801

    Authors:
    Carrie Li BA; Patricia Zadnik; Steve Cho; MacLean Nasrallah MD, PhD; Love Buch; H. Isaac Chen MD; John Y.K. Lee MD

    Study Design:
    Clinical trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2018 Annual Meeting - Late Breaking Science

    Introduction: Stereotactic needle biopsies provide a minimally invasive option for the diagnosis of intracranial lesions but are limited by inconclusive diagnoses on frozen pathology. Additional samples and prolonged procedure times increase risk of complications. 5-Aminovelunic acid (5-ALA) and sodium fluorescein have previously demonstrated potential as diagnostic adjuvants for rapid intraoperative pathology. Stereotactic biopsy with near-infrared (NIR) fluorescence has not been reported. We identified five representative cases utilizing the NIR-fluorescent dye Indocyanine-Green (ICG), administered in a high dose, delayed manner.

    Methods: We identified five patients enrolled in an ongoing IRB-approved protocol who underwent Second Window ICG (SWIG)-guided stereotactic biopsy for diagnosis of suspected glioma or tumor recurrence. Up to 5 mg/kg ICG was administered approximately 24 hours prior to surgery. Stereotactic core needle biopsies were conducted in the standard fashion, targeting regions of suspected tumor using intraoperative frameless navigation. Core samples were examined under standard visible light and for fluorescence using conventional NIR imaging platforms intraoperatively. Findings were correlated with frozen and final tumor pathology for all cases.

    Results: Ten biopsy specimens were obtained in five patients. Three (30%) did not fluoresce and did not demonstrate tumor on preliminary or final pathology, including a non-gadolinium-enhancing sample taken proximal to the final target. The remaining 7 (70%) samples fluoresced, of which 5 (71%) contained positively identifiable tumor. One sample (14%) contained necrosis; however, a separate fluorescent biopsy from this patient demonstrated glioblastoma. Fluorescence was also noted in a patient with radiation treatment effect. Overall fluorescence characteristics were highly concordant with both preliminary and final diagnoses.

    Conclusions: SWIG provides rapid intraoperative confirmation of gadolinium-enhancing, pathologic brain tissue during stereotactic biopsy. Because the mechanism of ICG accumulation is similar to that of gadolinium in permeating neoplastic or inflammatory brain tissue, we believe SWIG-guided stereotactic biopsy can improve surgical efficiency by improving confidence in acquisition of target tissue.

    Patient Care: The objective of stereotactic brain biopsy is to safely acquire diagnostic specimen. However, inconclusive intraoperative pathology and prolonged procedure times mean surgeons must decide whether additional trajectories and samples are required to render a diagnosis. SWIG and other fluorescence-guided surgical techniques are a promising means of reducing complications.

    Learning Objectives: "By the conclusion of this session, participants should be able to: 1) Describe the utility of near-infrared imaging in stereotactic biopsy 2) Discuss, in small groups, the postulated relationship between biopsy fluorescence and regions of gadolinium-enhancement on MRI 3) Identify entities who would benefit from this adjunct intraoperative visualization technique."

    References: 1. Uematsu Y, Owai Y, Okita R, Tanaka Y, Itakura T. The usefulness and problem of intraoperative rapid diagnosis in surgical neuropathology. Brain Tumor Pathol. 2007;24(2):47-52. doi:10.1007/s10014-007-0219-z 2. Millesi M, Kiesel B, Mischkulnig M, et al. Value of 5-ALA in frameless stereotactic brain biopsies. Photodiagnosis Photodyn Ther. 2017;17:A74. doi:10.1016/j.pdpdt.2017.01.167 3. Kiesel B, Millesi M, Woehrer A, et al. 5-ALA–induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients. Neurosurg Focus. 2018;44(6):E7. doi:10.3171/2018.3.FOCUS1859 4. Millesi M, Kiesel B, Woehrer A, et al. Analysis of 5-aminolevulinic acid–induced fluorescence in 55 different spinal tumors. Neurosurg Focus. 2014;36(2):E11. doi:10.3171/2013.12.FOCUS13485 5. von Campe G, Moschopulos M, Hefti M. 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies. Acta Neurochir (Wien). 2012;154(4):585-588. doi:10.1007/s00701-012-1290-8 6. Thien A, Han JX, Kumar K, et al. Investigation of the usefulness of fluorescein sodium fluorescence in stereotactic brain biopsy. Acta Neurochir (Wien). 2018;160(2):317-324. doi:10.1007/s00701-017-3429-0 7. Rey-Dios R, Hattab EM, Cohen-Gadol AA. Use of intraoperative fluorescein sodium fluorescence to improve the accuracy of tissue diagnosis during stereotactic needle biopsy of high-grade gliomas. Acta Neurochir (Wien). 2014;156(6):1071-1075. doi:10.1007/s00701-014-2097-6 8. Catapano G, Sgulò FG, Seneca V, Iorio G, de Notaris M, di Nuzzo G. Fluorescein-assisted stereotactic needle biopsy of brain tumors: a single-center experience and systematic review. Neurosurg Rev. January 2018:1-10. doi:10.1007/s10143-018-0947-z 9. Moriuchi S, Yamada K, Dehara M, et al. Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. J Neurosurg. 2011;115(2):278-280. doi:10.3171/2011.4.JNS102137 10. Widhalm G, Minchev G, Woehrer A, et al. Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies. Neurosurg Rev. 2012;35(3):381-391. doi:10.1007/s10143-012-0374-5 11. Marbacher S, Klinger E, Schwyzer L, et al. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases. Neurosurg Focus. 2014;36(2):E10. doi:10.3171/2013.12.FOCUS13464 12. Senders JT, Muskens IS, Schnoor R, et al. Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results. Acta Neurochir (Wien). 2017;159(1):151-167. doi:10.1007/s00701-016-3028-5 13. Jiang JX, Keating JJ, Jesus EM De, et al. Optimization of the enhanced permeability and retention effect for near-infrared imaging of solid tumors with indocyanine green. Am J Nucl Med Mol Imaging. 2015;5(4):390-400. http://www.ncbi.nlm.nih.gov/pubmed/26269776. Accessed July 16, 2018. 14. Lee JYK, Thawani JP, Pierce J, et al. Intraoperative Near-Infrared Optical Imaging Can Localize Gadolinium-Enhancing Gliomas During Surgery. Neurosurgery. 2016;79(6):856-871. doi:10.1227/NEU.0000000000001450 15. Lee JYK, Pierce JT, Zeh R, et al. Intraoperative Near-Infrared Optical Contrast Can Localize Brain Metastases. World Neurosurg. 2017;106:120-130. doi:10.1016/j.wneu.2017.06.128 16. Lee JYK, Pierce JT, Thawani JP, et al. Near-infrared fluorescent image-guided surgery for intracranial meningioma. J Neurosurg. 2018;128(2):380-390. doi:10.3171/2016.10.JNS161636 17. Nishihara M, Sasayama T, Kudo H, Kohmura E. Morbidity of stereotactic biopsy for intracranial lesions. Kobe J Med Sci. 2011;56(4):E148-53. http://www.ncbi.nlm.nih.gov/pubmed/21937861. Accessed July 16, 2018. 18. Malikova H, Liscak R, Latnerova I, Guseynova K, Syrucek M, Pytlik R. Complications of MRI-guided stereotactic biopsy of brain lymphoma. Neuro Endocrinol Lett. 2014;35(7):613-618. http://www.ncbi.nlm.nih.gov/pubmed/25617885. Accessed July 16, 2018. 19. Malone H, Yang J, Hershman DL, Wright JD, Bruce JN, Neugut AI. Complications Following Stereotactic Needle Biopsy of Intracranial Tumors. World Neurosurg. 2015;84(4):1084-1089. doi:10.1016/j.wneu.2015.05.025 20. Kongkham PN, Knifed E, Tamber MS, Bernstein M. Complications in 622 cases of frame-based stereotactic biopsy, a decreasing procedure. Can J Neurol Sci. 2008;35(1):79-84. http://www.ncbi.nlm.nih.gov/pubmed/18380282. Accessed July 17, 2018. 21. Chen C-C, Hsu P-W, Erich Wu T-W, et al. Stereotactic brain biopsy: Single center retrospective analysis of complications. Clin Neurol Neurosurg. 2009;111(10):835-839. doi:10.1016/j.clineuro.2009.08.013 22. Della Puppa A, De Pellegrin S, d’Avella E, et al. 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature. Acta Neurochir (Wien). 2013;155(6):965-972. doi:10.1007/s00701-013-1660-x 23. Schucht P, Seidel K, Beck J, et al. Intraoperative monopolar mapping during 5-ALA–guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome. Neurosurg Focus. 2014;37(6):E16. doi:10.3171/2014.10.FOCUS14524 24. Waters Jd, Gonda D, Reddy H, Kasper E, Warnke P, Chen C. Diagnostic yield of stereotactic needle-biopsies of sub-cubic centimeter intracranial lesions. Surg Neurol Int. 2013;4(4):176. doi:10.4103/2152-7806.110677

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy